Ameritas Investment Partners, Inc. Artivion, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Artivion, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 3,885 shares of AORT stock, worth $111,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,885
Previous 3,885
-0.0%
Holding current value
$111,810
Previous $99,000
4.04%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AORT
# of Institutions
174Shares Held
35.8MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$191 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$80.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$80.4 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$79 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$70.5 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.16B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...